Membership Directory

Dyax Corporation

Category: Research Products and Instrumentation
Phone: (617) 225-2500
Fax: (617) 225-2501
Website: http://www.dyax.com

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammation. Dyax utilizes its proprietary drug discovery technology, phage display, to identify antibody, small protein and peptide compounds for clinical development. Dyax’s lead product candidate is DX-88, a recombinant small protein that is currently in clinical trials for its therapeutic potential in two separate indications: hereditary angioedema, HAE (second Phase 3 trial) and on-pump cardiothoracic surgery, CTS (Phase 2 trial). Dyax identified DX-88 and other compounds in its pipeline using its phage display technology and leverages this technology broadly with 70+ revenue. generating licenses and collaborations

Back to list

Recent Jobs